Filing Flows

Filing Flows › Omada Health (OMDA) › Q3 2026 › vs Q3 2025

Omada Health (OMDA) Q3 2026 vs Q3 2025 (year over year)

Omada Health's revenue rose $23.3M (+34%) from $68.0M in Q3 2025 to $91.3M in Q3 2026. The biggest changes: Services +$22.2M (+35%); Hardware +$1.1M (+22%). Gross margin 75.9% against 66.3% (+9.6 pts).

Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%, net earnings $6.6M, operating cash flow $15.1M. The chart draws each line against Q3 2025, the increases inside each band.

Omada Health: what changed, Q3 2026 vs Q3 2025Omada Health: what changed, Q3 2026 vs Q3 2025Gross profit$24.2MServices$22.2MOperating expenses$16.9MPre-tax earnings$9.7MNet earnings$9.7MWorking capital & other−$7.4MOperating profit$7.3MSales & marketing$6.2MGeneral & admin$5.7MFree cash flow (OCF − capex)$5.4M

Margins

Q3 2026Q3 2025Change
Gross margin75.9%66.3%+9.6 pts
Operating margin5.3%-3.7%+9.0 pts
Net margin7.2%-4.7%+11.8 pts
Free cash flow margin16.5%14.1%+2.3 pts

Every line

LineQ3 2026Q3 2025Change%
Services$85.1M$62.9M$22.2M+35%
Hardware$6.2M$5.1M$1.1M+22%
Revenue$91.3M$68.0M$23.3M+34%
Gross profit$69.3M$45.1M$24.2M+54%
Cost of revenue$22.0M$23.0M−$935K-4%
Other income, net$1.7M−$665K$2.4M—
Operating profit$4.8M−$2.5M$7.3M—
Operating expenses$64.5M$47.6M$16.9M+35%
Pre-tax earnings$6.6M−$3.2M$9.7M—
Research & development$15.3M$10.3M$5.0M+48%
Sales & marketing$29.1M$22.9M$6.2M+27%
General & admin$20.1M$14.3M$5.7M+40%
Net earnings$6.6M−$3.2M$9.7M—
Depreciation & amortization$1.7M$1.4M$322K+24%
Share-based compensation$5.9M$3.5M$2.3M+65%
Working capital & other$1.1M$8.4M−$7.4M-87%
Operating cash flow$15.1M$10.1M$5.0M+49%
Free cash flow (OCF − capex)$15.0M$9.6M$5.4M+57%
Capital expenditures$118K$537K−$419K-78%

Questions

How much did Omada Health's revenue grow year over year in Q3 2026?

Omada Health's revenue rose $23.3M (+34%) from $68.0M in Q3 2025 to $91.3M in Q3 2026.

What drove Omada Health's revenue change in Q3 2026?

Services +$22.2M (+35%); Hardware +$1.1M (+22%).

Q3 2026 results → · Compare in the interactive Sankey →